title: Anticlastogenic and anticarcinogenic potential of Thai bitter gourd fruits.
abstract: Thai bitter gourd fruits (Momordica charantia Linn., TBG) has been previously demonstrated to possess phase II detoxificating enzymes inducing properties, as well as the ability to reduce phase I carcinogen activating enzyme activity in rat liver. In addition, it was partially inhibited 7,12-dimethylbenz(a)anthracene (DMBA)- induced mammary gland carcinogenesis in female Sprague-Dawley rats. In this study, we therefore examined the anticlastogenic and anticarcinogenic effect of TBG against clastogens, cyclophosphamide (CYP) and DMBA, in mice using the in vivo erythrocyte micronucleus assay and azoxymethane (AOM)-induced colon carcinogenesis in rats, respectively. For anticlastogenicity test, male mice were fed with modified AIN-76 diets containing 6.25% and 12.5% of ground freeze-dried TBG for 2 weeks prior to administration of clastogens till the end of experiment. Blood samples were collected and counted for reticulocytes by using the fluorescent microscope. For anticarcinogeicity test, male Wistar rats were fed with modified AIN-76 diets containing 5% and 10% ground freeze-dried TBG for 2 weeks prior to, during and 1 week after the completion of AOM administration (15 mg/kg once a week for 2 weeks). It was found that TBG at 6.25% resulted in a significant reduction in micronucleated peripheral reticulocytes (MNRETs) induced by only CYP. Study on anticarcinogenic potential demonstrated that rats fed with TBG diets at the concentration tested developed significantly higher incidence as well as the multiplicities of colon tumors than the control group. These results demonstrated that Thai bitter gourd fruits possesses anticlastogenic potential against clastogen in the mouse. Interestingly, it had no preventive potential against AOM-induced colon carcinogenesis in rat, rather increasing the incidence of colonic neoplasm when giving during the initiation stage.
authors.affiliation: Laboratory Animal Section, Research Division, National Cancer Institute, Bangkok, Thailand. pkupradi@yahoo.com
authors.forename: Piengchai
authors.initials: P
authors.lastname: Kupradinun
authors.forename: Anong
authors.initials: A
authors.lastname: Tepsuwan
authors.forename: Nopsaran
authors.initials: N
authors.lastname: Tantasi
authors.forename: Nuntana
authors.initials: N
authors.lastname: Meesiripun
authors.forename: Anudep
authors.initials: A
authors.lastname: Rungsipipat
authors.forename: Wannee R
authors.initials: WR
authors.lastname: Kusamran
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D016587:Antimutagenic Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D001397:Azoxymethane; D001551:Benz(a)Anthracenes / Q000494:pharmacology; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D003520:Cyclophosphamide / Q000494:pharmacology; D005260:Female; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D015162:Micronucleus Tests; D029777:Momordica charantia / Q000201:enzymology*; D009153:Mutagens / Q000494:pharmacology; D010936:Plant Extracts / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012156:Reticulocytes / Q000187:drug effects
chemical_list: D016588:Anticarcinogenic Agents; D016587:Antimutagenic Agents; D000970:Antineoplastic Agents; D001551:Benz(a)Anthracenes; D009153:Mutagens; D010936:Plant Extracts; C046810:7,12-dihydroxymethylbenz(a)anthracene; D003520:Cyclophosphamide; D001397:Azoxymethane